Ana Gowani, MD
Rheumatology · Greenville, SCNPI 1053843524
Payments from drug & device makers
Across 222 payments — averaging $20.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$915
- AbbVie$745
- Johnson & Johnson$429
- Lilly USA, LLC$351
- AstraZeneca$324
- Novartis$208
- plus $2K from 18 others
What the payments were for
- Food & beverage$4,32096%
- Education$1784%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 60 | $915 |
| AbbVie | 39 | $745 |
| Johnson & Johnson | 16 | $429 |
| Lilly USA, LLC | 17 | $351 |
| AstraZeneca(2 entities) | 15 | $324 |
| Novartis | 9 | $208 |
| Aurinia Pharma U.S., Inc. | 8 | $205 |
| Sanofi | 6 | $177 |
| UCB, Inc. | 7 | $164 |
| Organon | 6 | $159 |
| E.r. Squibb & Sons, L.L.C. | 7 | $151 |
| Pfizer | 7 | $146 |
| Fresenius Kabi USA, LLC | 4 | $86 |
| GSK | 5 | $82 |
| Radius Health, Inc. | 3 | $70 |
| Sandoz | 3 | $62 |
| Almatica Pharma LLC | 2 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
| Genentech USA, Inc. | 2 | $31 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $31 |
| ANI Pharmaceuticals, Inc. | 1 | $30 |
| Tersera Therapeutics LLC | 1 | $26 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
How this compares
$4,498 in reported general payments places this provider in the 45th percentile of 123 rheumatology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 35 | $270,839 |
| Hydroxychloroquine Sulfate | 179 | $7,126 |
| MethotrexateMethotrexate Sodium | 136 | $3,481 |
| Leflunomide | 45 | $2,343 |
| Prednisone | 216 | $1,523 |
| Celecoxib | 71 | $1,344 |
| Colchicine | 27 | $925 |
| Azathioprine | 22 | $793 |
| Duloxetine Hcl | 21 | $648 |
| Pregabalin | 11 | $645 |
| Allopurinol | 87 | $555 |
| Diclofenac Sodium | 19 | $243 |
| Alendronate Sodium | 33 | $238 |
| Leucovorin Calcium | 21 | $164 |
| Meloxicam | 57 | $153 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Greenville
- Alan BrownGreenville$947K
- Richard KimGreenville$706K
- Long Huynh-DucGreenville$475K
- Jeffrey LawsonGreenville$370K
- Corey EphrussiGreenville$54K
- Suhail KumarGreenville$34K
- David ZelmanGreenville$25K
- Gulzar MerchantGreenville$18K
- Ezinma EzealahGreenville$12K
- Stephen MullisGreenville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.